Literature DB >> 11888897

Inhibition of cancer cell growth by BRCA2.

Shao-Chun Wang1, Ruping Shao, Annie Y Pao, Su Zhang, Mien-Chie Hung, Li-Kuo Su.   

Abstract

The breast cancer susceptibility gene BRCA2 has been suggested to function as a "caretaker" of the genome. Cells without wild-type BRCA2 are deficient in repairing DNA damage. However, whether BRCA2 can also suppress oncogenesis by regulating cell proliferation remains to be determined. To address this question, the expression of wild-type BRCA2 protein was reconstituted, in an either constitutive or regulated manner, in the pancreatic cancer cell line Capan-1, which expresses only a mutant BRCA2. Expression of wild-type BRCA2 inhibited cell proliferation in culture and suppressed tumor growth in animals. Our results showed that, in addition to the DNA repair function, BRCA2 also suppresses tumor development by inhibiting cancer cell growth.

Entities:  

Mesh:

Year:  2002        PMID: 11888897

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Authors:  Arnaldo A Arbini; Margherita Greco; Jorge L Yao; Patricia Bourne; Ersilia Marra; Jer-Tsong Hsieh; Paul A di Sant'agnese; Loredana Moro
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.

Authors:  Gong Yang; Bin Chang; Fan Yang; Xiaoqing Guo; Kathy Qi Cai; Xue Sherry Xiao; Huamin Wang; Subrata Sen; Mien-Chie Hung; Gordon B Mills; Sandy Chang; Asha S Multani; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Clin Cancer Res       Date:  2010-04-27       Impact factor: 12.531

3.  Cell cycle-dependent regulation of the bi-directional overlapping promoter of human BRCA2/ZAR2 genes in breast cancer cells.

Authors:  Smita Misra; Shvetank Sharma; Anupriya Agarwal; Sheetal V Khedkar; Manish K Tripathi; Mukul K Mittal; Gautam Chaudhuri
Journal:  Mol Cancer       Date:  2010-03-04       Impact factor: 27.401

Review 4.  BRCA2 and pancreatic cancer.

Authors:  Ali Naderi; Fergus J Couch
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 5.  DNA damage response genes and the development of cancer metastasis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

6.  BRCA2 suppresses cell proliferation via stabilizing MAGE-D1.

Authors:  Xin-xia Tian; Deepak Rai; Jun Li; Chaozhong Zou; Yujie Bai; David Wazer; Vimla Band; Qingshen Gao
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

7.  Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

Authors:  Leandro E Mainetti; Xiaoning Zhe; Jonathan Diedrich; Allen D Saliganan; Won Jin Cho; Michael L Cher; Elisabeth Heath; Rafael Fridman; Hyeong-Reh Choi Kim; R Daniel Bonfil
Journal:  Int J Cancer       Date:  2014-05-20       Impact factor: 7.396

8.  A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors.

Authors:  Bastiaan Evers; Eva Schut; Eline van der Burg; Tanya M Braumuller; David A Egan; Henne Holstege; Pauline Edser; David J Adams; Richard Wade-Martins; Peter Bouwman; Jos Jonkers
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

9.  DNA double strand break repair and its association with inherited predispositions to breast cancer.

Authors:  Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

10.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.